GlassScriptPhysician profile
Amani Sargios
NPI 1598105967
$11,532.90
in general payments reported to CMS, 2019-2025
45 companies · $1,799 in 2025
The $1,799 reported for 2025 was more than what 92% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,606 · 2022: $2,391 · 2023: $2,974 · 2024: $2,763 · 2025: $1,799.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,536.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,535.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,619.42 | 2021-2025 | Qulipta, Ubrelvy, Vraylar |
| Novo Nordisk INC | $1,311.67 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $1,159.11 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Pfizer INC. | $968.37 | 2021-2025 | |
| Lilly USA, LLC | $958.97 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Astrazeneca Pharmaceuticals LP | $766.70 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $551.33 | 2021-2025 | Jardiance, Synjardy, Tradjenta |
| Bayer Healthcare Pharmaceuticals INC. | $497.06 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $362.92 | 2021-2025 | |
| Kowa Pharmaceuticals America, INC. | $283.18 | 2021-2024 | Livalo, Seglentis |
| Exact Sciences Corporation | $260.31 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Merck Sharp & Dohme LLC | $238.39 | 2021-2025 | Verquvo, Capvaxive, Gardasil 9 |
| Otsuka America Pharmaceutical, INC. | $228.15 | 2024-2025 | Rexulti |
| Astellas Pharma US INC | $211.31 | 2023-2024 | Veozah, Myrbetriq |
| Janssen Pharmaceuticals, INC | $169.40 | 2022-2023 | Xarelto |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $155.69 | 2022-2023 | Eliquis, Camzyos |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $151.65 | 2021-2025 | Xifaxan |
| Axsome Therapeutics, INC. | $149.14 | 2023-2025 | Auvelity, Sunosi |
| Amarin Pharma, INC. | $137.79 | 2021-2022 | |
| Esperion Therapeutics, INC. | $111.97 | 2022-2024 | Nexletol |
| Sanofi-Aventis U.S. LLC | $110.14 | 2024 | |
| Amgen INC. | $104.96 | 2023-2025 | Repatha, Otezla, Otezla |
| Lundbeck LLC | $103.63 | 2023-2025 | Rexulti |
| Ironwood Pharmaceuticals, INC | $89.29 | 2021-2023 | Linzess |
| Paratek Pharmaceuticals, INC. | $72.87 | 2021-2022 | |
| Amneal Pharmaceuticals LLC | $69.98 | 2023-2025 | Unithroid |
| Abbott Laboratories | $65.65 | 2021-2025 | Freestyle Libre 3 |
| Coloplast Corp | $58.13 | 2025 | |
| Baxter Healthcare | $57.62 | 2023-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Csl Behring | $48.70 | 2022-2023 | Hizentra |
| Daiichi Sankyo INC. | $48.44 | 2021 | |
| Dexcom, INC. | $46.26 | 2023 | Dexcom G6 Transmitter |
| Insulet Corporation | $46.18 | 2022-2025 | Omnipod |
| Currax Pharmaceuticals LLC | $43.27 | 2023 | Contrave, Onzetra Xsail |
| Biohaven Pharmaceuticals, INC. | $37.39 | 2021 | |
| Mylan Specialty L.P. | $34.42 | 2021-2023 | Yupelri |
| Arbor Pharmaceuticals, INC. | $29.19 | 2021 | |
| Alnylam Pharmaceuticals INC. | $28.86 | 2022 | |
| Eisai INC. | $25.78 | 2025 | |
| Alexion Pharmaceuticals, INC. | $25.59 | 2023 | Strensiq |
| Genzyme Corporation | $21.45 | 2023 | |
| Idorsia Pharmaceuticals US INC | $20.16 | 2023 | Quviviq |
| Boston Scientific Corporation | $19.68 | 2025 | Watchman Flx |
| Rgh Enterprises LLC | $17.12 | 2024 | |
| Medtronic, INC. | $15.61 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amani Sargios listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.